Casdin Private Growth Equity Fund, L.P.'s Net Worth
$3.47 Million
Who is Casdin Private Growth Equity Fund, L.P.?
Casdin Private Growth Equity Fund, L.P. has an estimated net worth of $3.47 Million. This is based on reported shares across multiple companies, which include Absci Corp, Tenaya Therapeutics, Inc., Verve Therapeutics, Inc., and STANDARD BIOTOOLS INC..
SEC CIK
Casdin Private Growth Equity Fund, L.P.'s CIK is 0001823061
Past Insider Trading and Trends
2021 was Casdin Private Growth Equity Fund, L.P.'s most active year for acquiring shares with 1 total transactions. Casdin Private Growth Equity Fund, L.P.'s most active month to acquire stocks was the month of May. 2021 was Casdin Private Growth Equity Fund, L.P.'s most active year for disposing of shares, totalling 1 transactions. Casdin Private Growth Equity Fund, L.P.'s most active month to dispose stocks was the month of May. 2021 saw Casdin Private Growth Equity Fund, L.P. paying a total of $0.00 for 620,571 shares, this is the most they've acquired in one year. In 2021 Casdin Private Growth Equity Fund, L.P. cashed out on 5,746,183 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Absci Corp (ABSI) Snapshot price: $4.02
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 7.72M |
$16.00 | $25,000,000.00 | 7.72M |
Jul 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tenaya Therapeutics, Inc. (TNYA) Snapshot price: $2.35
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.59M |
$15.00 | $12,750,000.00 | 3.59M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
STANDARD BIOTOOLS INC. (LAB) Snapshot price: $1.94
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.46% | 250K |
$2.19 | $546,750.00 | 54.03M |
Aug 27
| |||
Form 4
| +0.70% | 750K |
$2.09 | $1,546,237.01 | 107.4M |
Aug 22 - Aug 26
| |||
Form 4
| +2.37% | 1.2M |
$1.59 | $1,913,520.00 | 51.78M |
Aug 14
| |||
Form 4
| +3.22% | 1.58M |
$1.62 | $2,559,641.38 | 50.58M |
Aug 9 - Aug 13
| |||
Form 4
| +1.11% | 1.07M |
$1.61 | $1,718,800.82 | 97.43M |
Aug 7 - Aug 8
| |||
Form 4
|
—
|
0
|
$2.05 |
—
| 47.28M |
Jun 18
| |||
Form 4
| +0.22% | 100K |
$2.60 | $260,000.00 | 46.08M |
May 23
| |||
Form 4
| +1.32% | 600K |
$2.57 | $1,541,795.00 | 45.98M |
May 20 - May 22
| |||
Form 4
| +3.07% | 1.35M |
$2.56 | $3,455,543.67 | 45.38M |
May 15 - May 17
| |||
Form 4
| +404.12% | 46.47M |
$2.75 | $127,780,009.50 | 57.96M |
Mar 18
| |||
Form 4
| +2.24% | 251.4K |
$2.57 | $646,168.85 | 11.5M |
Mar 4 - Mar 5
| |||
Form 4
|
∞
| 13.99M |
—
|
—
| 13.99M |
Jan 5
| |||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 620.57K |
—
|
—
| 620.57K |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||